Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

14.4K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
14.4K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

11.0K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
11.0K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

6.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.8K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

9.3K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.3K
Cancer02:18

Cancer

53.3K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
53.3K
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

6.3K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
6.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An analysis pipeline for understanding 6-thioguanine effects on a mouse tumour genome.

Cancer immunology, immunotherapy : CII·2024
Same author

X-ray microtomography reveals a lattice-like network within aortic elastic lamellae.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology·2021
Same author

Coupled Mass-Spectrometry-Based Lipidomics Machine Learning Approach for Early Detection of Clear Cell Renal Cell Carcinoma.

Journal of proteome research·2020
Same author

An improved catalogue of putative synaptic genes defined exclusively by temporal transcription profiles through an ensemble machine learning approach.

BMC genomics·2019
Same author

von Hippel-Lindau mutants in renal cell carcinoma are regulated by increased expression of RSUME.

Cell death & disease·2019
Same author

GenIO: a phenotype-genotype analysis web server for clinical genomics of rare diseases.

BMC bioinformatics·2018

Related Experiment Video

Updated: Jan 2, 2026

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.6K

A pan-cancer somatic mutation embedding using autoencoders.

Martin Palazzo1,2,3, Pierre Beauseroy2, Patricio Yankilevich4

  • 1Instituto de Investigación en Biomedicina de Buenos Aires (IBioBA)-CONICET-Partner Institute of the Max Planck Society, Godoy Cruz 2390, Buenos Aires, C1425FQD, Argentina.

BMC Bioinformatics
|December 13, 2019
PubMed
Summary
This summary is machine-generated.

This study introduces a novel neural network pipeline for analyzing complex cancer mutation data. The method effectively reduces data dimensionality, aiding in the exploration and classification of tumor subtypes across various cancer types.

Keywords:
AutoencoderCancer genomicsKernel learning

More Related Videos

Detecting Somatic Genetic Alterations in Tumor Specimens by Exon Capture and Massively Parallel Sequencing
11:02

Detecting Somatic Genetic Alterations in Tumor Specimens by Exon Capture and Massively Parallel Sequencing

Published on: October 18, 2013

19.8K
Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
13:24

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

Published on: April 11, 2016

12.2K

Related Experiment Videos

Last Updated: Jan 2, 2026

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.6K
Detecting Somatic Genetic Alterations in Tumor Specimens by Exon Capture and Massively Parallel Sequencing
11:02

Detecting Somatic Genetic Alterations in Tumor Specimens by Exon Capture and Massively Parallel Sequencing

Published on: October 18, 2013

19.8K
Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
13:24

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

Published on: April 11, 2016

12.2K

Area of Science:

  • Computational Biology
  • Genomics
  • Machine Learning in Oncology

Background:

  • Next-generation sequencing generates vast amounts of cancer genome data, necessitating advanced computational methods for interpretation.
  • Machine learning approaches are increasingly employed to unravel the complexity of cancer disease using large tumor datasets.
  • High-dimensional tumor samples with germline and somatic mutation data require sophisticated computational modeling.

Purpose of the Study:

  • To develop and apply a neural network-based pipeline for analyzing complex somatic mutation data in cancer.
  • To discover lower-dimensional representations of tumor mutation profiles for enhanced data interpretation.
  • To accurately classify tumor subtypes using machine learning models applied to mutation data.

Main Methods:

  • An autoencoder model was utilized to learn compressed representations (embeddings) of somatic mutation data.
  • Kernel learning and hierarchical cluster analysis were employed to evaluate the quality of the learned embeddings.
  • Support vector machine models were trained on the embeddings for tumor subtype classification.

Main Results:

  • The autoencoder successfully generated lower-dimensional representations of somatic mutation data from 40 tumor types and subtypes.
  • The learned embeddings preserved significant biological signals from the original high-dimensional data.
  • Support vector machine models achieved accurate classification of tumor subtypes based on the reduced-dimension embeddings.

Conclusions:

  • The developed pipeline effectively maps high-dimensional tumor mutation data into a lower-dimensional latent space.
  • The resulting embeddings facilitate easier exploration of intra- and inter-tumor heterogeneity.
  • This approach enables accurate classification of tumor samples within the pan-cancer somatic mutation landscape.